DrugDashboards

Market view

perindopril erbumine · Powder

3 marketed package NDCs · 3 active manufacturers

Most dispensed: 2 mg · Tablet · #100 tablets/bottle · 4 mg · Tablet · #100 tablets/bottle · 8 mg · Tablet · #100 tablets/bottle

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for perindopril erbumine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Angiotensin Converting Enzyme Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Perindopril erbumine in shortage right now?
No. FDA does not currently list Perindopril erbumine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Perindopril erbumine?
4 companies have marketed Perindopril erbumine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Perindopril erbumine cost?
The typical pharmacy pays about $0.4948 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.